The Application of Crisis Intervention in Middle-Aged and Young Patients with Acute Myocardial Infarction after PCI
DOI:
https://doi.org/10.1532/hsf.3771Keywords:
Crisis intervention, middle-aged and young adults, acute myocardial infarction, PCI, mental state, quality of life, hope levelAbstract
Objective: To investigate the effect of crisis intervention in middle-aged and young patients with acute myocardial infarction after percutaneous coronary stent implantation (PCI).
Methods: A total of 108 middle-aged and young patients with acute myocardial infarction undergoing PCI were selected from July 2018 to July 2019 in the Department of
Cardiology, Hai'an County People's Hospital. They were divided into two groups, according to a random number table, with 54 cases in each group. The control group implemented routine postoperative intervention, and the intervention group implemented postoperative crisis intervention. The changes in the two groups' sense of crisis, mental state, quality of life and hope level before and after the intervention were compared.
Results: The emotional, behavioral, and cognitive scores of the intervention group were lower than those of the control group after 4 weeks of intervention (P < .05). The mental state scores of the intervention group were lower than those of the control group (P < .05). Also, the various quality of life scores were higher than those of the control group (P < .05). The intervention group’s hope level scores were higher than the control group (P < .05) after 4 weeks of intervention.
Conclusion: The application of crisis intervention to middle-aged and young patients with acute myocardial infarction after PCI can reduce the sense of crisis, improve their mental state and quality of life, and raise the level of hope.
References
Bårdsgjerde EK, Landstad BJ, Hole T, et al. 2020. Nurses' perceptions of patient participation in the myocardial infarction pathway [J]. Nurs Open. 7(5):1606-1615.
Boinska J, Koziński M, Kasprzak M, et al. 2020. Diurnal variations in tissue factor and tissue factor pathway inhibitor concentrations in relation to on-treatment platelet reactivity: an analysis of patients with acute myocardial infarction [J]. Platelets. 31(7):877-883.
D'Rosario D, Currey J, Considine J, et al. 2020. Clinical deterioration in patients with ST-elevation myocardial infarction during and for 24 h after percutaneous coronary intervention: An observational study [J]. Aust Crit Care. 33(5):458-462.
Köppen J, Maier CB, Busse R, et al. 2018. What are the motivating and hindering factors for health professionals to undertake new roles in hospitals? A study among physicians, nurses and managers looking at breast cancer and acute myocardial infarction care in nine countries [J]. Health Policy. 122(10):1118-1125.
Liu H, Zhang J, Yu J, et al. 2020. Prognostic value of serum albumin-to-creatinine ratio in patients with acute myocardial infarction: Results from the retrospective evaluation of acute chest pain study [J]. Medicine (Baltimore). 99(35):e22049.
Moghaddam N, Wong GC, Cairns JA, et al. 2018. Association of Anemia With Outcomes Among ST-Segment-Elevation Myocardial Infarction Patients Receiving Primary Percutaneous Coronary Intervention [J]. Circ Cardiovasc Interv. 11(12):e007175.
Pandey A, Keshvani N, Vaughan-Sarrazin MS, et al. 2020. Evaluation of Risk-Adjusted Home Time After Acute Myocardial Infarction as a Novel Hospital-Level Performance Metric for Medicare Beneficiaries [J]. Circulation. 142(1):29-39.
Plakht Y, Gilutz H, Arbelle JE, et al. 2020. Sex and Ethnic Disparities in Health-Related Outcomes Following Acute Myocardial Infarction in Israel [J]. Isr Med Assoc J. 22(5):303-309.
Plakht Y, Gilutz H, Shiyovich A. 2018. Sodium levels during hospitalization with acute myocardial infarction are markers of in-hospital mortality: Soroka acute myocardial infarction II (SAMI-II) project [J]. Clin Res Cardiol. 107(10):956-964.
Plakht Y, Greenberg D, Gilutz H, et al. 2020. Mortality and healthcare resource utilization following acute myocardial infarction according to adherence to recommended medical therapy guidelines [J]. Health Policy. 124(11):1200-1208.
Poursafar Z, Joukar F, Hasavari F, et al. 2019. The Associations between Meat Group Consumption and Acute Myocardial Infarction Risks in an Iranian Population: a Case-Control Study [J]. Clin Nutr Res. 8(2):159-168.
Sen A, Vardaxis I, Lindqvist BH, et al. 2019. Systematic assessment of prescribed medications and short-term risk of myocardial infarction - a pharmacopeia-wide association study from Norway and Sweden [J]. Sci Rep. 9(1):8257.
Sharif Nia H, Gorgulu O, Pahlevan Sharif S, et al. 2020. Prevalence of Acute Myocardial Infarction and Changing Meteorological Conditions in Iran: Fuzzy Clustering Approach [J]. Iran J Public Health. 49(5):923-930.
Shiyovich A, Axelrod M, Gilutz H, et al. 2019. Early Versus Late New-Onset Atrial Fibrillation in Acute Myocardial Infarction: Differences in Clinical Characteristics and Predictors [J]. Angiology. 70(10):921-928.
Silber H, Shiyovich A, Gilutz H, et al. 2017. hospital survivors of acute myocardial infarction. Soroka Acute Myocardial Infarction II (SAMI-II) project [J]. Int J Cardiol. 228:694-699.
Suzuki Y, Ito K, Yamamoto K, et al. 2018. Predictors of improvements in exercise capacity during cardiac rehabilitation in the recovery phase after coronary artery bypass graft surgery versus acute myocardial infarction [J]. Heart Vessels. 33(4):358-366.
Twigg DE, Kutzer Y, Jacob E, et al. 2019. A quantitative systematic review of the association between nurse skill mix and nursing-sensitive patient outcomes in the acute care setting [J]. J Adv Nurs. 75(12):3404-3423.
Worcester MU, Goble AJ, Elliott PC, et al. 2019. Pediatric Mild Traumatic Brain Injury and Population Health: An Introduction for Nursing Care Providers [J]. Heart Lung Circ. 28(12):1812-1818.
Zhang Z, Bai J, Huang Y, et al. 2020. Implementation of a clinical nursing pathway for percutaneous coronary intervention: A randomized controlled trial protocol [J]. Medicine (Baltimore). 99(43):e22866.
Zullo AR, Riester MR, Erqou S, et al. 2020. Comparative Effectiveness of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in Older Nursing Home Residents After Myocardial Infarction: A Retrospective Cohort Study [J]. Drugs Aging. 37(10):755-766.
Published
How to Cite
Issue
Section
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).
